RXO (NYSE: RXO) reported Q4 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.49 billion.

RXO expects first-quarter 2026 adjusted EBITDA to be between $5 million and $12 million.

In Brokerage, the company expects overall volume to decline by 5% to 10% year-over-year and gross margin to be between 11% and 13% in the first quarter.

For earnings history and earnings-related data on RXO (RXO) click here.